Anifrolumab – July 2026

  • Brand names:
    • Saphnelo®
  • Pharmaceutical Company:
    • ASTRAZENECA PTY LTD
  • Condition/Indication: Systemic lupus erythematosus (SLE)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026